Seguici
IT
IT

Uno degli obiettivi principali di Life4me+ è quello di prevenire nuovi casi di HIV e altre infezioni sessualmente trasmissibili, epatite C e tubercolosi.

L'app aiuta a stabilire una comunicazione anonima tra i medici e le persone sieropositive. Ti consente di organizzare comodamente l'orario di assunzione dei farmaci e di impostare promemoria nascosti e personalizzati.

Tutte le notizie / Marzo 2017

Archivio

✕
22 marzo 2017
3672
HIV Drives Evolution Of Tuberculosis Bacterium

HIV Drives Evolution Of Tuberculosis Bacterium

The bacteria responsible for TB, Mycobacterium tuberculosis, can evolve in response to HIV, a finding from the study was carried out by a team led by Anastasia Koch from the University of Cape Town, suggest, that could influence the design of TB vaccines for regions where ...
21 marzo 2017
3803
Tuberculosis deaths fall in Europe, ECDC reports

Tuberculosis deaths fall in Europe, ECDC reports

The number of people developing and dying from tuberculosis (TB) is decreasing in Europe, but among the most vulnerable - including prisoners, migrants, and people living with HIV - there have been disturbing increases, the Reuters reported on Monday. Figures from the European ...
21 marzo 2017
3756
Is Dolutegravir Monotherapy Effective in Treating HIV?

Is Dolutegravir Monotherapy Effective in Treating HIV?

The authors of the multicenter study performed in the Netherlands hypothesised that Dolutegravir (DTG) monotherapy (DTG 50 mg by mouth daily) was non-inferior to ART in sustaining virologic suppression. The results of this study was reported at CROI 2017. Although dolutegravir ...
20 marzo 2017
3456
Researchers Map Pathways To Protective Antibodies For An HIV Vaccine

Researchers Map Pathways To Protective Antibodies For An HIV Vaccine

A Duke Health-led research team has described both the pathway of HIV protective antibody development and a synthetic HIV outer envelope mimic that has the potential to induce the antibodies with vaccination. "A goal for an HIV-1 vaccine is to induce broadly neutralising ...
20 marzo 2017
3646
Insulin May Help Restore Neurocognitive Functions in HIV Patients

Insulin May Help Restore Neurocognitive Functions in HIV Patients

Delivering insulin within the nasal cavity helped prevent neuroinflammation, neuronal injury, and restored neurobehavioral function, a study in HIV mouse models showed. HIV-associated neurocognitive disorders (HAND) describe a spectrum disorder of neurocognitive dysfunctions ...
20 marzo 2017
3723
Lurking HIV Detected in a Major Biomarker Discovery

Lurking HIV Detected in a Major Biomarker Discovery

A unique protein that gives away the presence of inactive HIV in the body has been discovered by a team scientists from the University of Montpellier in France. According to the article in Nature, researchers achieved a significant milestone in HIV research by identifying ...
16 marzo 2017
3720
Trump Proposes To Cut NIH Funding By 19 Percent

Trump Proposes To Cut NIH Funding By 19 Percent

The NIH would absorb $5.8 billion cut under President Trump’s first budget proposal. This is about 19 percent of its current $30.3 billion budget. The agency funds research into a broad array of diseases and conditions, including HIV, cancer, developmental disorders, heart ...
15 marzo 2017
3981
“Art Hearts Fashion” Raise HIV/AIDS Awareness During LA Fashion Week

“Art Hearts Fashion” Raise HIV/AIDS Awareness During LA Fashion Week

AIDS Healthcare Foundation (AHF) will partner with Art Hearts Fashion to raise awareness about HIV/AIDS as part of the Fall/Winter 2017 LA Fashion Week collection of shows. The aim of this action is to promote sexual health through HIV/STD testing, treatment and condom usage. Founded ...
15 marzo 2017
3624
Early Antibody Therapy Has "Taught" The Macaques' Immune System To Fight HIV

Early Antibody Therapy Has "Taught" The Macaques' Immune System To Fight HIV

A new approach to the HIV therapy on the monkey model (SHIV) proposed recently in the Nature journal by a group of microbiologists from the U. S. and Germany. Michele Nussentswijg from the Rockefeller University in New York (USA), said, the use of two novel antibodies, ...
15 marzo 2017
5210
GeoVax And American Gene Technologies Announced Collaboration For HIV Functional Cure

GeoVax And American Gene Technologies Announced Collaboration For HIV Functional Cure

GeoVax Labs announced its collaboration with American Gene Technologies International (AGT) for the administration of Phase 1 clinical trial studying the companies’ consolidated technologies as a functional cure for HIV infection. AGT plans to conduct a Phase 1 clinical ...
Utilizziamo i cookie su questo sito per migliorare la tua esperienza.
Facendo clic su qualsiasi pulsante di questo sito Web, dai il tuo consenso per l'impostazione dei cookie.